ILT4, in turn, promotes macrophage infiltration and M2 polarization.[245] Moreover, in NSCLC patients with osimertinib resistance, the EGFRL792F mutation following the acquisition of T790M promotes STAT3 Tyr705 phosphorylation. This evidence concerns the gene LILRB2 and non-small cell lung carcinoma.